Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc-finger DNA binding proteins contain structural motifs called zinc fingers, typically stabilized by the coordination of zinc ions with cysteine and histidine residues. The classical C2H2 zinc finger motif is the most common DNA-binding domain in eukaryotic transcription factors. These proteins bind DNA, often in a sequence-specific manner, and regulate gene expression, chromatin structure, and many other cellular processes. The protein family is highly versatile—members can also bind RNA, other proteins, and lipids, influencing cell cycle, apoptosis, differentiation, and stress responses. Dysregulation of zinc-finger DNA binding proteins is implicated in diverse diseases, prominently cancer, and their domains form the basis of therapeutically important gene editing tools such as zinc finger nucleases.
Gene editing via engineered zinc finger nucleases (ZFNs): targeted DNA cleavage for mutagenesis or gene correction Modulation of transcription factor activity (regulating gene expression at the DNA level)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc-finger DNA binding protein (ZNF).